ADMA Biologics, Inc. logo

ADMA Biologics, Inc.

NASDAQ:ADMA

Overview | Financials
Company Name ADMA Biologics, Inc.
Symbol ADMA
Currency USD
Price 17.4
Market Cap 4,113,186,000
Dividend Yield 0%
52-week-range 4.16 - 23.64
Industry Biotechnology
Sector Healthcare
CEO Mr. Adam S. Grossman
Website https://www.admabiologics.com

An error occurred while fetching data.

About ADMA Biologics, Inc.

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an

Related Stocks

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

15.64 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

52.91 USD

Akoya Biosciences, Inc. logo

Akoya Biosciences, Inc.

AKYA

2.49 USD

Protagonist Therapeutics, Inc. logo

Protagonist Therapeutics, Inc.

PTGX

41.49 USD

Sight Sciences, Inc. logo

Sight Sciences, Inc.

SGHT

3.57 USD

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI

1.56 USD

Repare Therapeutics Inc. logo

Repare Therapeutics Inc.

RPTX

1.32 USD

Agenus Inc. logo

Agenus Inc.

AGEN

2.83 USD

Financials

Numbers are in millions USD

Numbers are in millions USD